However, de novo dominant KIF1A mutations may result in a phenotypic spectrum overlapping with AR SPG30 including mental retardation, speech delay, epilepsy, optic nerve atrophy, thinning of the corpus callosum, periventricular white matter lesion and microcephaly [85–88]. The gene discussed is AR; the disease is epilepsy.